Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals REGN
$ 704.47 -0.53%

Квартальный отчет 2024-Q3
добавлен 31.10.2024

report update icon

Regeneron Pharmaceuticals Мультипликаторы 2011-2024 | REGN

Мультипликаторы по годам Regeneron Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

25.3 19.3 8.3 14.8 17.4 18.5 33.7 40.3 68.1 120.4 67.6 22.1 -36.3

P/S

7.6 6.9 4.2 6.1 4.7 6.8 6.9 7.4 10.6 14.9 13.6 12.0 18.1

EPS

37.0 40.5 76.4 32.6 19.4 22.6 11.3 8.6 6.2 3.4 4.2 7.9 -2.5

EV (Enterprise Value)

105 млрд 87.1 млрд 70.5 млрд 55.9 млрд 38.8 млрд 46.8 млрд 42.2 млрд 38.1 млрд 44.4 млрд 42.6 млрд 29.2 млрд 17.2 млрд 8.41 млрд

EBITDA per Share

41.9 47.4 87.3 35.4 22.2 24.9 20.9 13.7 12.9 8.86 8.18 5.22 -1.92

EV/EBITDA

7.6 13.9 14.5 16.3 17.8 24.8 32.0 46.5 35.5 33.6 -45.1

PEG

0.92 0.57 0.15 0.58 -1.2 0.18 1.06 1.04 0.87 -5.99 -1.49 0.05 0.38

P/B

3.9 3.7 3.6 4.7 3.3 5.2 6.6 8.1 11.8 16.5 14.7 13.3 16.6

P/CF

21.8 16.7 9.4 19.9 18.4 25.0 39.0 37.5 66.3 102.2 67.1 -133.5 -40.5

ROE %

15.22 19.14 43.03 31.86 19.08 27.91 19.51 20.13 17.40 13.69 21.74 60.24 -45.65

ROA %

11.95 14.85 31.75 20.47 14.29 20.83 13.67 12.84 11.34 8.99 14.38 36.06 -16.75

ROCE %

15.58 20.91 47.67 32.44 17.39 24.63 27.26 23.22 26.09 26.06 28.66 23.88 -17.46

Current Ratio

4.7 4.5 3.8 2.8 3.7 4.5 3.8 2.6 3.6 3.3 6.0 7.4 4.4

DSO

153.0 170.4 103.9 111.9 124.0 122.0 122.7 121.0 130.6 131.7 154.7 183.5 84.4

DIO

- - - - 660.5 968.0 667.5 486.4 221.7 229.4 165.3 123.8 1173.6

DPO

- - - - 195.1 183.5 163.8 164.4 131.0 177.2 145.5 168.3 2401.2

Операционный цикл

153.0 170.4 103.9 111.9 784.6 1090.0 790.2 607.4 352.3 361.1 319.9 307.3 1258.0

Финансовый цикл

153.0 170.4 103.9 111.9 589.5 906.5 626.4 443.0 221.3 184.0 174.4 139.0 -1143.3

Все данные представлены в валюте USD

Мультипликаторы поквартально Regeneron Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

12.4 13.25 6.7 9.48 9.05 7.64 - 12.31 7.9 9.12 - 15.37 29.51 10.58 10.9 7.98 8.19 5.69 7.25 6.12 1.77 4.23 7.58 5.5 5.12 4.44 1.62 3.64 3.66 2.36 2.41 2.53 1.88 1.74 1.49 2.04 1.89 0.74 0.89 0.89 0.89 0.89 0.98 1.44 0.89 1.02 4.92 2.02 0.81 0.12 -0.58 -0.68 -0.69 -0.49

EBITDA per Share

- - 8.03 - - 9.77 - 13.7 10.3 12.5 - 19.4 31.9 11.2 - 11.6 7.04 6.89 - 8.18 3.83 4.88 - 6.78 6.42 5.61 - 6.29 5.88 4.44 - 4.18 3.25 3.38 - 4.3 3.66 2.93 - 8.56 2.39 2.3 - 2.72 1.81 1.68 - 2.42 1.11 0.33 - -0.39 -0.5 -0.38

ROE %

16.37 15.83 14.23 17.70 19.79 19.87 15.14 24.60 27.92 44.29 39.25 49.68 47.86 35.51 31.86 28.58 26.98 20.59 19.08 21.31 22.06 26.61 27.91 21.37 20.90 20.91 19.50 22.37 22.00 20.10 20.13 18.68 18.48 19.40 17.40 16.70 14.47 12.68 14.11 15.51 19.21 20.16 21.71 54.21 62.35 64.04 59.91 11.47 -16.74 -35.77 -45.65 -12.84 -12.87 -8.94

ROA %

12.78 12.36 11.11 13.77 15.39 15.92 12.14 19.04 17.49 31.91 27.59 34.29 32.30 23.11 20.47 19.12 18.74 14.82 14.29 15.93 16.48 19.87 20.83 15.82 15.18 14.91 13.67 15.32 14.69 13.08 12.84 11.98 11.93 12.59 11.34 10.92 9.52 8.40 9.36 10.29 12.73 13.34 14.38 33.71 38.12 38.85 36.06 9.41 -4.50 -12.91 -16.75 -4.71 -4.72 -3.28

ROCE %

15.06 15.27 15.51 18.43 19.68 20.81 17.39 28.10 33.09 49.85 42.12 51.67 50.52 34.35 21.86 28.51 25.62 22.51 13.83 20.99 21.49 25.75 20.74 29.85 31.81 33.66 25.08 33.23 32.27 29.87 22.11 32.85 35.43 38.31 27.93 36.39 57.96 56.99 57.65 61.32 41.14 40.78 28.07 44.32 48.44 47.36 25.06 13.02 -15.26 -34.71 -32.89 -12.03 -12.42 -8.44

Current Ratio

4.6 4.6 4.7 4.4 4.6 4.6 4.5 4.4 - 4.1 3.8 3.7 3.4 3.1 2.8 2.8 2.8 2.8 4.0 4.0 4.0 4.0 3.9 3.9 3.9 3.9 3.3 3.3 3.3 3.3 2.8 2.8 2.8 2.8 2.9 2.9 2.9 2.9 3.0 3.0 3.0 2.9 3.0 3.0 3.0 3.0 2.5 2.5 2.5 2.5 1.6 1.6 1.6 1.6

DSO

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

Финансовый цикл

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

Все данные представлены в валюте USD